rs1061147

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000186.4(CFH):​c.921A>C​(p.Ala307Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.634 in 1,612,176 control chromosomes in the GnomAD database, including 328,805 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.63 ( 30604 hom., cov: 31)
Exomes 𝑓: 0.63 ( 298201 hom. )

Consequence

CFH
NM_000186.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -0.175

Publications

91 publications found
Variant links:
Genes affected
CFH (HGNC:4883): (complement factor H) This gene is a member of the Regulator of Complement Activation (RCA) gene cluster and encodes a protein with twenty short consensus repeat (SCR) domains. This protein is secreted into the bloodstream and has an essential role in the regulation of complement activation, restricting this innate defense mechanism to microbial infections. Mutations in this gene have been associated with hemolytic-uremic syndrome (HUS) and chronic hypocomplementemic nephropathy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Oct 2011]
CFH Gene-Disease associations (from GenCC):
  • C3 glomerulonephritis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • atypical hemolytic-uremic syndrome
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • basal laminar drusen
    Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hemolytic uremic syndrome, atypical, susceptibility to, 1
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • complement factor H deficiency
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Doyne honeycomb retinal dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dense deposit disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 1-196685194-A-C is Benign according to our data. Variant chr1-196685194-A-C is described in ClinVar as Benign. ClinVar VariationId is 294488.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.175 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.925 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000186.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CFH
NM_000186.4
MANE Select
c.921A>Cp.Ala307Ala
synonymous
Exon 7 of 22NP_000177.2
CFH
NM_001014975.3
c.921A>Cp.Ala307Ala
synonymous
Exon 7 of 10NP_001014975.1A0A0D9SG88

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CFH
ENST00000367429.9
TSL:1 MANE Select
c.921A>Cp.Ala307Ala
synonymous
Exon 7 of 22ENSP00000356399.4P08603
ENSG00000289697
ENST00000696032.1
c.921A>Cp.Ala307Ala
synonymous
Exon 7 of 27ENSP00000512341.1A0A8Q3SIA1
CFH
ENST00000630130.2
TSL:1
c.921A>Cp.Ala307Ala
synonymous
Exon 7 of 10ENSP00000487250.1A0A0D9SG88

Frequencies

GnomAD3 genomes
AF:
0.630
AC:
95518
AN:
151684
Hom.:
30581
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.578
Gnomad AMI
AF:
0.520
Gnomad AMR
AF:
0.729
Gnomad ASJ
AF:
0.662
Gnomad EAS
AF:
0.947
Gnomad SAS
AF:
0.720
Gnomad FIN
AF:
0.562
Gnomad MID
AF:
0.666
Gnomad NFE
AF:
0.618
Gnomad OTH
AF:
0.656
GnomAD2 exomes
AF:
0.676
AC:
169659
AN:
250890
AF XY:
0.671
show subpopulations
Gnomad AFR exome
AF:
0.573
Gnomad AMR exome
AF:
0.831
Gnomad ASJ exome
AF:
0.666
Gnomad EAS exome
AF:
0.954
Gnomad FIN exome
AF:
0.563
Gnomad NFE exome
AF:
0.617
Gnomad OTH exome
AF:
0.657
GnomAD4 exome
AF:
0.635
AC:
927090
AN:
1460374
Hom.:
298201
Cov.:
48
AF XY:
0.636
AC XY:
461970
AN XY:
726556
show subpopulations
African (AFR)
AF:
0.578
AC:
19307
AN:
33416
American (AMR)
AF:
0.821
AC:
36630
AN:
44634
Ashkenazi Jewish (ASJ)
AF:
0.654
AC:
17056
AN:
26098
East Asian (EAS)
AF:
0.940
AC:
37277
AN:
39658
South Asian (SAS)
AF:
0.694
AC:
59860
AN:
86234
European-Finnish (FIN)
AF:
0.559
AC:
29873
AN:
53414
Middle Eastern (MID)
AF:
0.630
AC:
3631
AN:
5760
European-Non Finnish (NFE)
AF:
0.616
AC:
684814
AN:
1110834
Other (OTH)
AF:
0.641
AC:
38642
AN:
60326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
17737
35474
53211
70948
88685
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18550
37100
55650
74200
92750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.630
AC:
95581
AN:
151802
Hom.:
30604
Cov.:
31
AF XY:
0.633
AC XY:
46991
AN XY:
74192
show subpopulations
African (AFR)
AF:
0.578
AC:
23939
AN:
41396
American (AMR)
AF:
0.730
AC:
11090
AN:
15200
Ashkenazi Jewish (ASJ)
AF:
0.662
AC:
2296
AN:
3468
East Asian (EAS)
AF:
0.948
AC:
4875
AN:
5144
South Asian (SAS)
AF:
0.720
AC:
3475
AN:
4824
European-Finnish (FIN)
AF:
0.562
AC:
5932
AN:
10564
Middle Eastern (MID)
AF:
0.654
AC:
191
AN:
292
European-Non Finnish (NFE)
AF:
0.618
AC:
41931
AN:
67900
Other (OTH)
AF:
0.656
AC:
1378
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1754
3509
5263
7018
8772
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
780
1560
2340
3120
3900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.618
Hom.:
97823
Bravo
AF:
0.643
Asia WGS
AF:
0.778
AC:
2704
AN:
3476
EpiCase
AF:
0.632
EpiControl
AF:
0.628

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
Age related macular degeneration 4 (2)
-
-
2
Basal laminar drusen (2)
-
-
2
Hemolytic uremic syndrome, atypical, susceptibility to, 1 (2)
-
-
1
Atypical hemolytic-uremic syndrome (1)
-
-
1
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II (1)
-
-
1
Factor H deficiency (1)
-
-
1
Factor H deficiency;C0730295:Basal laminar drusen;C1853147:Age related macular degeneration 4;C2931788:Atypical hemolytic-uremic syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.9
DANN
Benign
0.43
PhyloP100
-0.17
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1061147; hg19: chr1-196654324; COSMIC: COSV62778986; API